nasdaq_markets · 2026-08-20
In recent trading, shares of Monopar Therapeutics Inc (Symbol: MNPR) have crossed above the average analyst 12-month target price of $120.23, changing hands for $123.84/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgr
Read the original at nasdaq_markets ↗
Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.
Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。